The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

In case you missed: RFK Jr. fires entire CDC vaccine advisory panel The Beyfortus shot was recommended by ACIP in 2023 for babies under 9 months old who are entering their first RSV season.

Kennedy selected a new team of medical professionals and scientists who are highly qualified and dedicated to public health.

CDC panel backs Merck's Enflonsia for RSV prevention in infants; FDA-approved therapy reduced hospitalizations by 84% in clinical trials.

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

In case you missed: RFK Jr. fires entire CDC vaccine advisory panel The Beyfortus shot was recommended by ACIP in 2023 for babies under 9 months old who are entering their first RSV season.